e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diagnostic features of tuberculosis II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
N. Makarova, T. Vaneeva, N. Kulikovskaya, V. Litvinov (Moscow, Russian Federation)
Source:
Annual Congress 2013 –Diagnostic features of tuberculosis II
Session:
Diagnostic features of tuberculosis II
Session type:
Thematic Poster Session
Number:
4430
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Makarova, T. Vaneeva, N. Kulikovskaya, V. Litvinov (Moscow, Russian Federation). Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?. Eur Respir J 2013; 42: Suppl. 57, 4430
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: An analysis of chronic renal faulire patients
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Diagnosis of latent tuberculosis infection in children with the useof different immunological methods
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
New-immigrant screening for latent tuberculosis infection: Reasons for non-treatment
Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis
Year: 2013
Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB)
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Diagnosing TB infection in children: analysis of discordances using in vitro tests and the tuberculin skin test
Source: Eur Respir J 2011; 37: 1166-1174
Year: 2011
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
Comparison of tuberculin skin test and in-vitro interferon gamma release tests in diagnosis of tuberculosis in children with household tuberculosis contact
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Detection TB infection using a skin tests with tuberculin and allergen recombinant (CFP-10-ESAT-6) in children and adolescents in Moscow in 2015
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept